---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-020939"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:19:20.860265+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biotricity exchanges common, options, warrants for Series C preferred with 40 votes per share

## Summary
- 14.14M common shares, 3.99M options, and 1.44M warrants exchanged for 1.96M Series C shares at a 10:1 ratio.
- Series C carries 40 votes per share; converts into 59.6% of common upon a $15M+ qualified financing.
- If no qualified financing by March 31, 2028, each Series C converts to 10 common shares.
- Exchange holders include officers and directors; transaction is exempt under Section 4(a)(2).

## SEC filing metadata
- accession: 0001493152-26-020939
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315226020939/0001493152-26-020939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315226020939/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-020939
- JSON: https://secwatch.observer/filing/0001493152-26-020939.json
- Plain text: https://secwatch.observer/filing/0001493152-26-020939.txt

## Source-grounded claims
- claim_id: aa53dee61ece1914aaecb95c868b20adf85e51b7
  claim: BIOTRICITY INC. entered into Exchange Agreement with Holders of Exchange Securities valued at Exchange of 14,144,325 common shares, options for 3,992,427 shares, and warrants for 1,436,216 share (effective 2026-05-01).
  evidence_excerpt: On May 1, 2026, Biotricity Inc. (the “Company”) entered into exchange agreements with holders (the “Exchange Holders”) of an aggregate of 14,144,325 shares of the Company’s common stock (the “Exchange Shares”), options (the “Exchange Options”) to purchase 3,992,427 shares of common stock of the Company, and warrants (the “Exchange Warrants,” and together with the Exchange Shares and the Exchange Options, the “Exchange Securities”) to purchase 1,436,216 shares of common stock of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315226020939/0001493152-26-020939-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.